Health And Medicine

A reversible chemical modification of rhodopsin, a receptor for light, plays a role in the degeneration of retinal cells. Read More

There is insufficient evidence to support findings, good or bad, for therapies currently used in adolescents and young adults with autism. Read More

A tool developed for one institution’s electronic health records can work at other institutions, potentially facilitating the use of these records in research studies. Read More

A new cooperative program between Vanderbilt University and Lipscomb University’s College of Pharmacy is focusing on the next generation of pharmaceutical researchers. By offering a pathway for students to earn both Pharm.D. and Ph.D. degrees, the program aims to boost the number of pharmacy-trained research scientists. Read More

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows. Read More

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments. Read More

Socioeconomic factors, African ancestry linked to risk for cancer-causing infection. Read More

Studies of Flu Tool, a computer application that guides health care decision-making, suggests that patients are willing to use these types of resources. Read More

Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity. Read More

Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs. Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells. Read More

Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma. Read More

A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases. Read More

MicroRNA “regulatory networks” generated at Vanderbilt aid search for biomarkers and new drugs to treat glioblastoma, the most common and lethal primary brain tumor. Read More

Smoking is more detrimental to lung function in individuals with high proportions of African ancestry. Read More

Anti-retroviral therapy can prevent tuberculosis, even in people with early HIV disease. Read More

A combination of biomarkers may reveal new clues about causes of and potential interventions for autism. Read More

A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old. Read More

An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation. Read More

A protein linked to aggressive bladder cancers could point to new strategies for treatment or prevention. Read More

Targeting immune system proteins may keep prostate cancer from spreading to bone. Read More